Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation

The purpose of this exploratory study was to investigate the combination of a radiopharmaceutical, nanoparticles and ultrasound (US) enhanced delivery to develop a clinically viable therapeutic strategy for tumours overexpressing the epidermal growth factor receptor (EGFR). Molecularly targeted radi...

Full description

Bibliographic Details
Main Authors:	Owen, J, Thomas, E, Menon, J, Gray, M, Skaripa-Koukelli, I, Gill, MR, Wallington, S, Miller, RL, Vallis, KA, Carlisle, R
Format:	Journal article
Language:	English
Published:	Elsevier 2019

Similar Items

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
by: Thomas, E, et al.
Published: (2019)

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
by: Gill, M, et al.
Published: (2018)

Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides
by: Bavelaar, BM, et al.
Published: (2021)

Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
by: Cai, Z, et al.
Published: (2008)

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
by: Chen, P, et al.
Published: (2002)

Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
by: Hu, M, et al.
Published: (2007)

Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
by: Cai, Z, et al.
Published: (2009)

Towards the synthesis and delivery of a halogenated MCT1 substrate
by: Skaripa-Koukelli, Eirini
Published: (2019)

The anti-tumor effect of the auger electron-emitting radiopharmaceutical, In-111-hEGF against MDA-MB-468 human breast cancer xenografts is tumor-size dependent.
by: Chen, P, et al.
Published: (2001)

Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic <i>Arabidopsis</i>
by: Weidong Qiang, et al.
Published: (2020-08-01)

ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
by: Cornelissen, B, et al.
Published: (2011)

Limitations of In-Vitro Labeling of Endothelial Cells with Indium-111 Oxine
by: H.M.H. Carr, et al.
Published: (1995-05-01)

Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
by: Wang, J, et al.
Published: (2001)

Indium-111 labeled leukocyte accumulation in extremity soft tissue sarcoma
by: Victor Fong, MD, et al.
Published: (2017-06-01)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
by: Skaripa-Koukelli, I, et al.
Published: (2021)

Bi-Functional Radiotheranostics of <sup>188</sup>Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells
by: Yi-Shu Huang, et al.
Published: (2021-02-01)

Use of micro- and nano-sized inertial cavitation nuclei to trigger and map drug release from cavitation-sensitive liposomes.
by: Graham, S, et al.
Published: (2013)

Subcellular targeting of theranostic radionuclides
by: Bavelaar, B, et al.
Published: (2018)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
by: Irini Skaripa-Koukelli, et al.
Published: (2021-10-01)

Monte Carlo investigation of S-values for 111In radionuclide therapy
by: Masoud Jabbari, et al.
Published: (2023-12-01)

Targeted radionuclide therapy in combined-modality regimens
by: Gill, M, et al.
Published: (2017)

A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer
by: Vallis, K, et al.
Published: (2005)

Production and Quality Control of Indium-111 Pentetreotide Radiopharmaceutical in Iran
by: S. Y Fazaeli Hoseini Nezhad, et al.
Published: (2017-08-01)

Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01)

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
by: Song, L, et al.
Published: (2017)

Construction of Yeast Recombinant Expression Vector Containing Human Epidermal Growth Factor (hEGF)
by: Jamal Mohammadian, et al.
Published: (2013-08-01)

Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting
by: Marco Verona, et al.
Published: (2021-02-01)

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.
by: Graham, S, et al.
Published: (2014)

Reentrant Behavior of the Density vs. Temperature of Indium Islands on GaAs(111)A
by: Artur Tuktamyshev, et al.
Published: (2020-07-01)

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells
by: Gill, MR, et al.
Published: (2020)

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
by: Cornelissen, B, et al.
Published: (2010)

Auger electron therapy using In-111-labelled F3 peptide
by: Cornelissen, B, et al.
Published: (2011)

Activity and Effectiveness of Recombinant hEGF Excreted by Escherichia coli BL21 on Wound Healing in Induced Diabetic Mice
by: Sriwidodo S, et al.
Published: (2020-09-01)

Liposome destruction by a collapsing cavitation microbubble: A numerical study
by: Jure Zevnik, et al.
Published: (2021-10-01)

Experimental study of proton induced cross-sections on natural cadmium leading to the production of In-111 radionuclide
by: Khandaker, Mayeen Uddin, et al.
Published: (2008)

Delivery of the Radionuclide <sup>131</sup>I Using Cationic Fusogenic Liposomes as Nanocarriers
by: Rejhana Kolašinac, et al.
Published: (2021-01-01)

Dosimetry of a Novel <sup>111</sup>Indium-Labeled Anti-P-Cadherin Monoclonal Antibody (FF-21101) in Non-Human Primates
by: Gregory Ravizzini, et al.
Published: (2023-09-01)

Correlation between radioactivity and chemotherapeutics of the 111In-VNB-liposome in pharmacokinetics and biodistribution in rats
by: Tsai TH, et al.
Published: (2012-02-01)

Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.
by: Feng-Yi Yang, et al.
Published: (2012-01-01)

Enhancement and mapping of ultrasonic drug release from thermosensitive liposomes by acoustic cavitation
by: Mylonopoulou, E
Published: (2011)